<DOC>
	<DOCNO>NCT00949533</DOCNO>
	<brief_summary>This open-label randomized 2 arm study determine emergence viral resistance participant seasonal influenza A infection treat oseltamivir . Eligible participant less equal ( &lt; /= ) 5 year age randomize receive oseltamivir either standard dose ( 30-75 milligram [ mg ] orally twice daily [ bid ] ) double dose ( 60-150 mg orally bid ) 5 day . Target sample size great ( &gt; ) 100 .</brief_summary>
	<brief_title>A Study Emergence Resistance With Oseltamivir ( Tamiflu ) Participants With Seasonal Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>positive rapid antigen test influenza A onset symptom influenza ( fever , least one respiratory symptom ) &lt; /=48 hour clinical suspicion infection respiratory virus influenza suspicion invasive bacterial infection evidence poorly control underlying disease know immunosuppression know allergy Oseltamivir woman pregnant plan get pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>